{"title":"中度至重度哮喘患者用布地奈德/福莫特罗替代沙美特罗/氟替卡松后的急诊会诊和肺活量测定值","authors":"Bernardo San MartÍn C., Vanesa Reveco R.","doi":"10.4067/s0717-73482023000300226","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":475771,"journal":{"name":"Revista Chilena De Enfermedades Respiratorias","volume":"133 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Consultas a urgencia y valores espirométricos tras el reemplazo de salmeterol/fluticasona por budesonida/formoterol en pacientes con asma moderada a grave\",\"authors\":\"Bernardo San MartÍn C., Vanesa Reveco R.\",\"doi\":\"10.4067/s0717-73482023000300226\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":475771,\"journal\":{\"name\":\"Revista Chilena De Enfermedades Respiratorias\",\"volume\":\"133 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista Chilena De Enfermedades Respiratorias\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4067/s0717-73482023000300226\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista Chilena De Enfermedades Respiratorias","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4067/s0717-73482023000300226","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Consultas a urgencia y valores espirométricos tras el reemplazo de salmeterol/fluticasona por budesonida/formoterol en pacientes con asma moderada a grave